Vishal Malkan of malkansview.com recommends buying L&T Finance Holdings with a stoploss at Rs 165 and target of Rs 185 and a buy also on Tata Motors DVR with a stoploss at Rs 225 and target of Rs 245.
Vishal Malkan of malkansview.com advises buying Bata India with a target of Rs 765.
Ashwani Gujral of ashwanigujral.com recommends buying Reliance Industries, Indraprastha Gas, HDFC Bank and Avanti Feeds.
Vijay Chopra of enochventures.com is of the view that one may buy NMDC with a target of Rs 130.
Vijay Chopra of enochventures.com advices buying Oil India with a target of Rs 335.
The approach of investing towards small to midcap in a scenario where the market is trading at record highs should be based on core fundamentals and not momentum in the stocks.
In an interview to CNBC-TV18's Surabhi Upadhyay and Reema Tendulkar, SP Tulsian shared his outlook and readings on the fundamentals of the market and specific stocks.
In an interview to CNBC-TV18, Deven Choksey, MD of KRChoksey Investment Managers shared his readings and outlook on specific stocks that came out with good quarterly numbers.
SP Tulsian of sptulsian.com tells CNBC-TV18 why he would not give a buy call on MRF stock which touched Rs 50,000-mark in trade Wednesday. He also shares his take on other tyre stocks.
In an interview to CNBC-TV18's Latha Venkatesh and Anuj Singhal, SP Tulsian of sptulsian.com shared his readings and outlook on specific stocks and sectors.
Here are a few stocks picked up by CNBC-TV18's analysts to focus today - stocks expected to gain are IGL, Vivimed Labs, Balaji Telefilms, ARSS infra, Motherson Sumi, Aurobindo Pharma, MPhasis and Tata Global Beverages while stocks expected to be under pressure are REC, Manpasand Beverages, Ahluwalia Contracts and Bajaj Finserv.
SP Tulsian of sptulsian.com is of the view that Vivimed Labs may test Rs 500 in next six months.
Pankaj Jain of Sunteck Wealthmax recommends going long in Vivimed Labs and Lupin.
Meghana V Malkan, malkansview.com advises buying Ranbaxy Labs for a target price of Rs 615 and selling Reliance Capital for a target price of Rs 495.
Pankaj Jain of Sunteck Wealthmax recommends buying DCB Bank and Vivimed Labs.
AK Prabhakar, Independent Advisor advises buying Eros International for a target price of Rs 300 and Bank of India for a target price of Rs 319.
Pankaj Jain of Sunteck Wealthmax recommends selling Indiabulls Real Estate and Jaiprakash Associates.
Pankaj Jain, Sunteck Wealthmax advises buying Vivimed Labs for a target price of Rs 375 and Pennar Industries for a target price of Rs 63.
Vivimed Labs may touch Rs 600, says Sudip Bandyopadhyay, MD & CEO, Destimoney Securities.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Buy Vivimed Labs above Rs 260, says Shardul Kulkarni of Angel Broking.
Investment advisor Ashish Chugh feels that one should buy Vivimed Labs.
Vivimed Labs has target of Rs 400, says SP Tulsian of sptulsian.com.